PPA
STSA

Parametric Portfolio Associates’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Parametric Portfolio Associates’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,921
Closed -$119K – 3688
2021
Q2 		$119K Sell
16,921
-116
-0.7% -$625 ﹤0.01% 3468
2021
Q1 		$101K Buy
17,037
+3,816
+29% +$23.1K ﹤0.01% 3969
2020
Q4 		$61K Buy
+13,221
New +$57K ﹤0.01% 3931

Other funds holding STSA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parametric Portfolio Associates's STSA Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q3 2021, closing a stake of 16,921 shares — an estimated $119K sold.

Parametric Portfolio Associates first reported a position in STSA in Q4 2020 and held it in 3 quarters. The position peaked at $119K in Q2 2021. 45 funds tracked by Wall St. Rank hold STSA as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 16,921 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $119K.
  • Parametric Portfolio Associates first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Parametric Portfolio Associates's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $119K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.